The Key Issues of the 2020 European Drug Report (EDR), available in 24 languages, presents a selection of the main findings from the EMCDDA’s latest analysis of the drug situation in Europe, chosen for their policy relevance and general interest. A set of top-level tables from the EMCDDA annual Statistical Bulletin are also included here.

The full version of this report, the 2020 EDR: Trends and Developments, is based on information provided to the EMCDDA by the EU Member States, the candidate country Turkey, and Norway, submitted through an annual reporting exercise. All groupings, aggregates and labels reflect the situation based on the available data in 2019 in respect to the composition of the European Union and the countries participating in EMCDDA reporting exercises in that year. Due to the time required for collation of data, annual data sets from national registries often reflect the reference year January to December 2018. Analysis of trends is based only on those countries providing sufficient data to describe changes over the period of interest. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed methodological information can be found in the online EMCDDA Statistical Bulletin which includes caveats and notes on the interpretation of data; qualifications on the analysis; and methodological information relating to the collection and interpretation of data and statistical information on the calculation of European and other averages, where interpolation may sometimes be used.